Apoptosis of cardiac myocytes in Gsα transgenic mice

Circulation Research

Volumn 84, Issue 1, 1999, Pages 34-42

  Geng, Yong Jian ^a   Ishikawa, Yoshihiro ^a   Vatner, Dorothy E ^a   Wagner, Thomas E ^b,c   Bishop, Sanford P ^d   Vatner, Stephen F ^a   Homcy, Charles J ^e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

^c CLEMSON UNIVERSITY   (United States)

^d Baptist Health   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Adenylyl cyclase; Cardiomyopathy; Catecholamine; Programmed cell death; adrenergic receptor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE RECEPTOR; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIOMYOPATHY; CHRONOTROPISM; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; NEWBORN; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0033593633     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.1.34     Document Type: Article

References (35)

1. Gilman A. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615-649.
2. Homcy CJ, Vatner SF, Vatner DE. Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol. 1991;53:137-159.
3. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
4. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, Vatner SF, Vatner DE. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993;91:907-914.
5. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85: 790-804.
6. Benjamin I, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
7. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homcy CJ, Vatner SF. Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gsα overexpression. Circ Res. 1996;78:517-524.
8. Iwase M, Uechi M, Vatner DE, Asia K, Shannon RP, Kudej RK, Wagner TE, Wight DC, Patrick TA, Ishikawa Y, Homcy CJ. Vatner SF. Cardiomyopathy induced by cardiac Gsα overexpression. Am J Physiol. 1997; 272:H585-H589.
9. Gaudin C, Ishikawa Y, Wight DC, Mahdavi V, Nadal-Ginard B, Wagner TE, Vatner DE, Homcy CJ. Overexpression of Gsα protein in the hearts of transgenic mice. J Clin Invest. 1995;95:1676-1683.
10. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science. 1994;264:582-586.
11. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995;268: 1350-1353.
12. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
13. Vatner DE, Asai K, Iwase M, Ishikawa Y, Wagner TE, Shannon RP, Homcy CJ, Vatner SF. Overexpression of myocardial Gs alpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. J Clin Invest. 1998;101:1916-1922.
14. Geng Y-J, Hellstrand K, Wennmalm A, Hansson GK. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor α. Cancer Res. 1996;56:866-874.
15. Geng Y-J, Wu Q, Muszynski M, Hansson G, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1beta. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
16. Gavrieli Y, Sherman Y, Ben SS. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
17. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1b converting enzyme. Am J Pathol. 1995; 147:251-266.
18. Holmer SR, Homcy CJ. G proteins in the heart: a redundant and diverse transmembrane signaling network. Circulation. 1991;84:1891-1902.
19. Warner HR. Aging and regulation of apoptosis. Curr Top Cell Regul. 1997;35:107-121.
20. Shaw R, Cianchetti R, Pleasure D, Kreider B. Basic fibroblast growth factor prevents cAMP-induced apoptosis in cultured Schwann cells. J Neurosci Res. 1997;47:400-404.
21. Mentz F, Mossalayi MD, Ouaaz F, Debre P. Involvement of cAMP in CD3 T cell receptor complex-and CD2-mediated apoptosis of human thymocytes. Eur J Immunol. 1995;25:1798-1801.
22. Hoshi S, Furutani-Seiki M, Seto M, Tada T, Asano Y. Prevention of TCR-mediated apoptosis by the elevation of cAMP. Int Immunol. 1994; 6:1081-1089.
23. Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 1997;272: 14860-14866.
24. Lader AS, Xiao YF, Ishikawa Y, Cui Y, Vatner DE, Vatner SF, Homcy CJ, Cantiello HF. Cardiac Gs alpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc Natl Acad Sci U S A. 1998;95:9669-9696.
25. Gottlieb RA, Birleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;1994:1621-1628.
26. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
27. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;97:2891-2897.
28. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
29. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW II. Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A. 1998;95:10140-10145.
30. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-adrenergic receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79:483-490.
31. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995;25:1225-1231.
32. Yao M, Keogh A, Spratt P, Dos RC, Kiessling PC. Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis? J Mol Cell Cardiol. 1996;28:95-101.
33. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
34. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec WG, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
35. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.